Replies to post #416242 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

"Right-to-Try" a good idea. But doesn't work.

Would be interesting to know if AVXL is engaged in supporting "Right to Try" initiatives.

This topic was discussed at length, in 2018 when the Right to Try rules were enacted. For a number of reasons Anavex will not be participating in any Right to Try initiatives involving blarcamesine for any CNS disease.

First, the patient taking the unapproved drug would have to buy and acquire it. Lots of issues just with that, regarding price, etc. Anavex doesn't choose to make blarcamesine pills available to the public in any way; lots of issues with that. What dosage would be sold? Who would do the dosage titrations, if they were required?

If a patient or administrating medical professional got things wrong and the patient suffered from an overdose, there could be all sorts of legal liabilities, for any and all parties.

The intent of the "Right to Try" law was laudable. But, in reality, it has proven unworkable. Has anyone heard of any new, unapproved drug being successfully used for anything? Too many potential problems for all three parties, the patients, their physicians, and the drug manufacturer.

[tredenwater2]

GBrown I wouldnt hold my breath in accessing the drug in the US. If a person in need of A2-73, they would, imo be better off inquiring or traveling down to AU with a visa and inquire about getting the drug in there program.

Theres a reason Dr. Missling skipped the US with trials and last time the topic of right to try came up I dont think they want the distraction right now, but that was then so who knows.

Sorry had to do a couple of typo repairs, long day and 3/4 way through a Crispy Pig whiskey Bloody Mary. Bloody Mary in a can, add 1/2 a lemon in the bottom of a salted glass of ice and enjoy!

Cheers

Tred